ArticleFrontiers in immunology2026

Identification of predictive biomarkers for nivolumab efficacy in non-small cell lung cancer through integrated serum lipidomics and proteomics analysis.

Hiroaki Hase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.